Inbio Ventures logo

Inbio Ventures

Europe, Moscow City, Russian Federation, Moscow

Description

Inbio Ventures is a venture capital firm that seeks to invest early stage and startups

Investor Profile

Inbio Ventures has made 15 investments, with 0 in the past 12 months and 7% as lead.

Stage Focus

  • Series B (40%)
  • Series C (27%)
  • Private Equity (7%)
  • Series F (7%)
  • Series D (7%)
  • Series E (7%)
  • Post Ipo Equity (7%)

Country Focus

  • United States (73%)
  • Canada (13%)
  • Australia (13%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Medical Device
  • Service Industry
  • Wellness
  • Bioinformatics
  • Diabetes
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Inbio Ventures frequently co-invest with?

Wellington Management
North America, Massachusetts, United States, Boston
Co-Investments: 4
Nextech Invest
Europe, Zurich, Switzerland, Zürich
Co-Investments: 3
Pharmstandard
Europe, Moscow City, Russian Federation, Moscow
Co-Investments: 8
Third Rock Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 2
Partner Fund Management
North America, California, United States, San Francisco
Co-Investments: 3
Frazier Healthcare Partners
North America, Washington, United States, Seattle
Co-Investments: 2
Bessemer Venture Partners
North America, California, United States, San Francisco
Co-Investments: 2
Abrams Capital
North America, Massachusetts, United States, Boston
Co-Investments: 2
BioStar Capital
North America, Michigan, United States, Petoskey
Co-Investments: 2
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 3

What are some of recent deals done by Inbio Ventures?

Neon Therapeutics

Cambridge, Massachusetts, United States

NEON Therapeutics is focused on unlocking the full potential of the immune system to recognize and attack cancer.

BioinformaticsBiotechnologyHealth CareMedicalTherapeutics
Series BDec 5, 2017
Amount Raised: $36,000,000
Neon Therapeutics

Cambridge, Massachusetts, United States

NEON Therapeutics is focused on unlocking the full potential of the immune system to recognize and attack cancer.

BioinformaticsBiotechnologyHealth CareMedicalTherapeutics
Series BJan 5, 2017
Amount Raised: $70,000,000
Avelas Biosciences

La Jolla, California, United States

Avelas Biosciences develops real-time luminous maps for oncologic surgeons to refer while in surgery.

BiotechnologyLife ScienceReal Time
Series CAug 18, 2016
Amount Raised: $20,000,000
TransMedics

Andover, Massachusetts, United States

TransMedics provides technology and clinical service solutions.

Health CareMedicalMedical DeviceService IndustryWellness
Private EquityJul 12, 2016
Amount Raised: $12,500,000
TransMedics

Andover, Massachusetts, United States

TransMedics provides technology and clinical service solutions.

Health CareMedicalMedical DeviceService IndustryWellness
Series FMay 26, 2016
Amount Raised: $51,200,000
Argos Therapeutics

Durham, North Carolina, United States

Argos Therapeutics develops immunotherapy treatments for cancers, infectious and autoimmune diseases, and transplantation rejection.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityMar 15, 2016
Amount Raised: $60,000,000
Allena Pharmaceuticals

Newton, Massachusetts, United States

Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.

BiotechnologyPharmaceuticalTherapeutics
Series CDec 9, 2015
Amount Raised: $53,000,000
Protagonist Therapeutics

Brisbane, Queensland, Australia

Protagonist Therapeutics develops orally-stable peptides to treat diseases that are currently addressed by injectable antibodies.

BiotechnologyHealth CareMedical
Series CJul 16, 2015
Amount Raised: $40,000,000
Jounce Therapeutics

Cambridge, Massachusetts, United States

Jounce Therapeutics is developing cancer immune-therapies to harness the immune system to attack cancerous cells and tumors.

BiotechnologyPharmaceuticalTherapeutics
Series BApr 23, 2015
Amount Raised: $56,000,000
enGene

Vancouver, British Columbia, Canada

enGene is a biotechnology company develops treatment for mucosal diseases through inducing therapeutic proteins of harmful proteins.

BiotechnologyDiabetesGeneticsHealth Care
Series BJan 26, 2015
Amount Raised: $11,500,000